Compounds > 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone
Page last updated: 2024-09-03

1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and pirenzepine

1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone has been researched along with pirenzepine in 1 studies

Compound Research Comparison

Studies
(1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)		Trials
(1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)		Recent Studies (post-2010)
(1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)		Studies
(pirenzepine)		Trials
(pirenzepine)		Recent Studies (post-2010) (pirenzepine)
26053,812587140

Protein Interaction Comparison

ProteinTaxonomy1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone (IC50)pirenzepine (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.6891
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.5856
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)0.6134
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)0.6222
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)0.6227
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)0.6227
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.3406
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)0.6281
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0291
Muscarinic acetylcholine receptor M1Mus musculus (house mouse)0.75
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.9556
Muscarinic acetylcholine receptor M4Mus musculus (house mouse)0.75
Muscarinic acetylcholine receptor M5Mus musculus (house mouse)0.75
Muscarinic acetylcholine receptor M3Mus musculus (house mouse)0.75
Muscarinic acetylcholine receptor M2Mus musculus (house mouse)0.51

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burger, JE; Czachura, JF; Gates, MR; Rasmussen, K1

Other Studies

1 other study(ies) available for 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and pirenzepine

ArticleYear
The novel atypical antipsychotic olanzapine, but not the CCK-B antagonist LY288513, blocks apomorphine-induced disruption of pre-pulse inhibition.
    Neuroscience letters, 1997, Jan-24, Volume: 222, Issue:1

    Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Apomorphine; Benzodiazepines; Dose-Response Relationship, Drug; Hormone Antagonists; Male; Olanzapine; Pirenzepine; Pyrazoles; Rats; Reflex, Startle

1997